Since ALS patients frequently develop insulin resistance [19], further research should evaluate how the progressive alterations of GPL levels in skeletal muscles could potentially contribute to metabolic alterations, or vice versa. The gene discussed is IL31RA; the disease is amyotrophic lateral sclerosis.